1
|
Wadasinghe RR, Kalansuriya P, Attanayake AP. Encapsulation of Gmelina arborea Roxb. and Spondias pinnata (L. F.) Kurz. Aqueous Extracts in Nanoliposomes: Synthesis, Characterization, and In Vitro Screening of Antidiabetic Activity. Chem Biodivers 2025; 22:e202402998. [PMID: 39720874 DOI: 10.1002/cbdv.202402998] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2024] [Revised: 12/17/2024] [Accepted: 12/23/2024] [Indexed: 12/26/2024]
Abstract
The present study aimed to synthesize, characterize, and determine the antidiabetic activity of Gmelina arborea and Spondias pinnata aqueous extract-encapsulated nanoliposomes (GAE-NL and SAE-NL). GAE-NL and SAE-NL were synthesized using modified emulsification and ultrasonication. The average size, polydispersity index, and zeta potential of GAE-NL and SAE-NL were 307 ± 2 nm, 0.429 ± 0.006, -19.95 ± 2.47 mV, and 389 ± 1 nm, 0.366 ± 0.011, and -27.27 ± 0.75 mV, respectively. The synthesized GAE-NL and SAE-NL had encapsulation efficiency (EE) of 84.33% ± 0.37% and 95.42% ± 0.56%, and loading capacity (LC) of 2.49% ± 0.08% and 23.83% ± 0.44%, respectively. Fourier transform infrared (FTIR) data indicated successful encapsulation of G. arborea and S. pinnata extracts into liposome matrix. The GAE-NL showed increased/comparable α-glucosidase and dipeptide peptidase-IV (DPP-IV) inhibitory activities and glucose uptake potency. The SAE-NL demonstrated superior α-glucosidase inhibitory activity compared to acarbose, a standard antidiabetic drug. In conclusion, GAE-NL and SAE-NL could be used to develop drug leads against diabetes mellitus.
Collapse
Affiliation(s)
| | - Pabasara Kalansuriya
- Department of Biochemistry, Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka
| | | |
Collapse
|
2
|
Jiao M, Kong W, Liu W, Dong Z, Yang J, Wei Z, Lu X, Wei Y, Zhuang J. Boosting the antibacterial potency of natural products through nanotechnologies. Int J Pharm 2025; 674:125437. [PMID: 40057213 DOI: 10.1016/j.ijpharm.2025.125437] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2025] [Revised: 03/01/2025] [Accepted: 03/06/2025] [Indexed: 03/17/2025]
Abstract
The advent of bacterial resistance has led to a notable challenge in effectively treating bacterial infections. This highlights the urgent need for the development of novel and effective drugs to combat bacterial infections. Medicinal plants, with their rich and diverse natural compounds, represent a valuable source for the discovery of novel antibacterial agents. Many of these natural compounds exhibit strong antibacterial functions, offering a promising direction for the development of antibacterial drugs. Furthermore, the application of nanotechnology in the development of antibacterial natural products has become a topic of considerable interest due to the advantages it offers, including the potential to enhance drug solubility. The efficacy of natural antibacterial agents is significantly enhanced through nanotechnology. This review offers a comprehensive overview of recent advances in the delivery of natural antibacterial compounds using a range of nanoformulation strategies.
Collapse
Affiliation(s)
- Min Jiao
- Graduate School, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China
| | - Weiwen Kong
- School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai 201203, China
| | - Wenjuan Liu
- School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai 201203, China
| | - Zirong Dong
- School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai 201203, China
| | - Jinlong Yang
- School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai 201203, China; Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200443, China
| | - Zibo Wei
- Graduate School, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China
| | - Xinrui Lu
- School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai 201203, China
| | - Yuning Wei
- School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai 201203, China
| | - Jie Zhuang
- Graduate School, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China.
| |
Collapse
|
3
|
Galli V, Golia D'Augè T, DI Pierro F, Cazzaniga M, Guasti L, Zerbinati N, Bertuccioli A, Khan A, D'Ovidio G, Iaculli F, Tibaldi V, Santangelo G, Fischetti M, Casorelli AF, DI Donato V, Giannini A, Musella A, Giancotti A, Monti M. Safety and efficacy of a class II medical device based on highly purified and standardized plant extracts in the management of post-menopausal patients with vulvar and vaginal atrophy: a single-center prospective observational study. Minerva Obstet Gynecol 2024; 76:343-352. [PMID: 38358384 DOI: 10.23736/s2724-606x.23.05409-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2024]
Abstract
BACKGROUND Despite the gold standard treatment for genitourinary syndrome of menopause (GSM) is based on the use of local or systemic estrogen-containing products, the typical long-term side effects of hormonal treatments and, most importantly, the contraindications in patients with history of breast and endometrial neoplasms do limit in some extent its use. As hyaluronic acid and some highly purified botanicals have clearly demonstrated their anti-inflammatory and mucosa-protecting properties, we have tested, in women with GSM, a class II vaginal medical device containing hyaluronate gel and a mucoadhesive active enriched with purified alkylamides from Zanthoxylum bungeanum, triterpenes from Centella asiatica and high molecular weight polysaccharides from Tamarindus indica. METHODS Our single-center, open-label, prospective and observational study was conducted on 50 menopausal women enrolled at the Department of Maternal-Fetal Medicine at Umberto I Polyclinic Hospital in Rome, Italy. Gel administration lasted 150 days and was performed daily for the first 12 days and every 48 hours for the remaining 138 days. Clinical evaluations were performed at baseline and after 12, 57 and 150 days. Besides product safety, main outcomes of our study were: 1) vaginal health (by Vaginal Health Index score [VHI]); 2) sexual quality of life (by Female Sexual Distress Scale [FSDS]); and 3) percentage of women declaring regular sexual activity. RESULTS The product was safe with no specific adverse events reported. It significantly improved VHI (about 5% after 57 days and 8% after 150 days), FSDS (about 7% after 57 days and 10% after 150 days), and sexual activity (about 20% after 150 days). It also reduced dryness, dyspareunia, burning, itching, and dysuria incidence, respectively by about 18%, 14%, 14%, 27% and 11% after 150 days. CONCLUSIONS In women with GSM, the intravaginal administration of a hyaluronate-based gel enriched with purified botanical actives endowed with anti-inflammatory and mucosal-protecting properties, reduced painful sensation during sexual acts and increased regular sexual activity.
Collapse
Affiliation(s)
- Valerio Galli
- Department of Maternal, Child Health and Urological Sciences, Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy
| | - Tullio Golia D'Augè
- Department of Maternal, Child Health and Urological Sciences, Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy
| | - Francesco DI Pierro
- Department of Science and Research, Velleja Research, Milan, Italy -
- Department of Medicine and Surgery, University of Insubria, Varese, Italy
| | | | - Luigina Guasti
- Department of Medicine and Surgery, University of Insubria, Varese, Italy
| | - Nicola Zerbinati
- Department of Medicine and Surgery, University of Insubria, Varese, Italy
| | | | - Amjad Khan
- Department of Biochemistry, Liaguat University of Medical and Health Sceinces, Jamshoro, Pakistan
| | - Giulia D'Ovidio
- Department of Maternal, Child Health and Urological Sciences, Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy
| | - Francesco Iaculli
- Department of Maternal, Child Health and Urological Sciences, Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy
| | - Valentina Tibaldi
- Department of Maternal, Child Health and Urological Sciences, Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy
| | - Giusi Santangelo
- Department of Maternal, Child Health and Urological Sciences, Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy
| | - Margherita Fischetti
- Department of Maternal, Child Health and Urological Sciences, Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy
| | - Assunta F Casorelli
- Department of Maternal, Child Health and Urological Sciences, Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy
| | - Violante DI Donato
- Department of Maternal, Child Health and Urological Sciences, Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy
| | - Andrea Giannini
- Department of Maternal, Child Health and Urological Sciences, Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy
| | - Angela Musella
- Department of Maternal, Child Health and Urological Sciences, Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy
| | - Antonella Giancotti
- Department of Maternal, Child Health and Urological Sciences, Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy
| | - Marco Monti
- Department of Maternal, Child Health and Urological Sciences, Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy
| |
Collapse
|
4
|
Muthumari B, Kumar BV, Kavitha M, Kumar JKJP, Arumugam N, Basu MJ. Optimization of sodium alginate-galactoxyloglucan blended hydrogel beads through ionotropic gelation method. Int J Biol Macromol 2023; 242:124630. [PMID: 37119903 DOI: 10.1016/j.ijbiomac.2023.124630] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2022] [Revised: 04/12/2023] [Accepted: 04/24/2023] [Indexed: 05/01/2023]
Abstract
Hydrogels are 3D crosslinking networks of hydrophilic biopolymers which can able to absorb and retain large amount of water. In this present study, the Sodium alginate (SA)- Galactoxyloglucan (GXG) blended hydrogel beads were prepared and optimized through two level optimization steps. Alginates and xyloglucan are the cell wall polysaccharides biopolymers obtained from the plant sources, Sargassum sp. and Tamarindus indica L. respectively. The extracted biopolymers were confirmed and characterized by UV-Spectroscopy, FT-IR, NMR and TGA analysis. Based on the hydrophilicity, non-toxicity and biocompatibility, SA-GXG hydrogel were prepared and optimized through two-level optimization steps. The optimized hydrogel bead formulation was characterized through FT-IR, TGA and SEM analysis. From the obtained result, it is found that the polymeric formulation GXG (2 % w/v)-SA (1.5 % w/v), cross-linker (CaCl2) concentration at 0.1 M and the cross-linking time at 15 Min showed significant swelling index. The optimized hydrogel beads are porous and show good swelling capacity and thermal stability. The optimized protocol of hydrogel beads may be useful in designing hydrogel beads for specific applications in agricultural, Biomedical and remediation sectors.
Collapse
Affiliation(s)
| | | | - Murugan Kavitha
- Department of Botany, Alagappa University, Karaikudi 630 003, India
| | | | - Nagarajan Arumugam
- Department of Biotechnology, Indian Institute of Technology Madras, Chennai, India
| | | |
Collapse
|
5
|
Sofiavizhimalar A, Sunithajasmine B, Rajalakshmi BS, Thamaraiselvi C, SumathiJones C, Pandey S, Alfarhan A, Muthusamy K, Chang SW, Ravindran B. Utilization of natural polysaccharide from Tamarindus indica L. seeds for the effective reduction of pollutants in cheese processed wastewater. CHEMOSPHERE 2022; 305:135241. [PMID: 35718031 DOI: 10.1016/j.chemosphere.2022.135241] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/16/2022] [Revised: 05/24/2022] [Accepted: 06/03/2022] [Indexed: 06/15/2023]
Abstract
The present study was targeted to treat the cheese factory processed wastewater by using natural coagulants. The results were compared with the CPCB wastewater discharge limit and most of the parameters were exceeded the standard limit. In the present investigation, the processed wastewater was subjected to treatment with Tamarindus indica L. plant seed as a coagulating agent. The processed wastewater was treated with Tamarindus indica L. seed powder which is rich in polysaccharides. The proximate analysis confirmed the presence of higher content of carbohydrates, protein, and fiber. Different dosages were used for the treatment. Accurately 0.4 gm was recorded as optimum dosage for the effective removal of pollutants includes 71% of TDS and 75% of COD from the cheese processed wastewater. The GC-MS analysis of raw and treated cheese processed wastewater was carried out and the results showed the degradation of toxic compounds and reduction of pollutants from the processed wastewater. FTIR analysis of T.indica L. seed powder disclosed various chemical group presence and proved higher efficiency in seed treatment.
Collapse
Affiliation(s)
- A Sofiavizhimalar
- Department of Biotechnology, Mother Teresa Women's University, Kodaikanal, 624101, India
| | - B Sunithajasmine
- Department of Biotechnology, Mother Teresa Women's University, Kodaikanal, 624101, India
| | - B Sowmiya Rajalakshmi
- Department of Biotechnology, Mother Teresa Women's University, Kodaikanal, 624101, India
| | - C Thamaraiselvi
- Department of Biotechnology, Mother Teresa Women's University, Kodaikanal, 624101, India.
| | - C SumathiJones
- Department of Pharmacology, Sree Balaji Dental College and Hospital, Pallikaranai, Chennai, 600 100, India.
| | - Sadanand Pandey
- Department of Chemistry, College of Natural Science, Yeungnam University, 280 Daehak-Ro, Gyeongsan, Gyeongbuk, 38541, Republic of Korea
| | - Ahmed Alfarhan
- Department of Botany and Microbiology, College of Science, King Saud University, P. O. Box 2455, Riyadh, 11451, Saudi Arabia
| | - Karnan Muthusamy
- Grassland and Forage Division, National Institute of Animal Science, Republic of Korea
| | - Soon Woong Chang
- Department of Environmental Energy and Engineering, Kyonggi University, Yeongtong-Gu, Suwon, Gyeonggi-Do, 16227, Republic of Korea
| | - Balasubramani Ravindran
- Department of Environmental Energy and Engineering, Kyonggi University, Yeongtong-Gu, Suwon, Gyeonggi-Do, 16227, Republic of Korea; Department of Medical Biotechnology and Integrative Physiology, Institute of Biotechnology, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Thandalam, Chennai, 602 105, Tamil Nadu, India.
| |
Collapse
|
6
|
Sayago-Ayerdi S, García-Martínez DL, Ramírez-Castillo AC, Ramírez-Concepción HR, Viuda-Martos M. Tropical Fruits and Their Co-Products as Bioactive Compounds and Their Health Effects: A Review. Foods 2021; 10:foods10081952. [PMID: 34441729 PMCID: PMC8393595 DOI: 10.3390/foods10081952] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2021] [Revised: 08/13/2021] [Accepted: 08/19/2021] [Indexed: 12/11/2022] Open
Abstract
Tropical and subtropical fruits are recognized as a source of a high content of bioactive compounds and health promoting properties due to their nutritional composition. These beneficial health effects are related to the content of several of these bioactive compounds, mainly flavonoids and non-flavonoid phenolics. Many of these compounds are common in different tropical fruits, such as epicatechin in mango, pineapple, and banana, or catechin in pineapple, cocoa or avocado. Many studies of tropical fruits had been carried out, but in this work an examination is made in the current literature of the flavonoids and non-flavonoid phenolics content of some tropical fruits and their coproducts, comparing the content in the same units, as well as examining the role that these compounds play in health benefits.
Collapse
Affiliation(s)
- Sonia Sayago-Ayerdi
- Tecnologico Nacional de Mexico, Instituto Tecnologico de Tepic, Av Tecnológico 2595, Col Lagos del Country, Tepic 63175, Nayarit Mexico, Mexico; (S.S.-A.); (D.L.G.-M.); (A.C.R.-C.); (H.R.R.-C.)
| | - Diana Laura García-Martínez
- Tecnologico Nacional de Mexico, Instituto Tecnologico de Tepic, Av Tecnológico 2595, Col Lagos del Country, Tepic 63175, Nayarit Mexico, Mexico; (S.S.-A.); (D.L.G.-M.); (A.C.R.-C.); (H.R.R.-C.)
| | - Ailin Cecilia Ramírez-Castillo
- Tecnologico Nacional de Mexico, Instituto Tecnologico de Tepic, Av Tecnológico 2595, Col Lagos del Country, Tepic 63175, Nayarit Mexico, Mexico; (S.S.-A.); (D.L.G.-M.); (A.C.R.-C.); (H.R.R.-C.)
| | - Heidi Rubí Ramírez-Concepción
- Tecnologico Nacional de Mexico, Instituto Tecnologico de Tepic, Av Tecnológico 2595, Col Lagos del Country, Tepic 63175, Nayarit Mexico, Mexico; (S.S.-A.); (D.L.G.-M.); (A.C.R.-C.); (H.R.R.-C.)
| | - Manuel Viuda-Martos
- IPOA Research Group, Centro de Investigación e Innovación Agroalimentaria y Agroambiental (CIAGRO-UMH), Agro-Food Technology Department, Miguel Hernández University, Orihuela, 03312 Alicante, Spain
- Correspondence: ; Tel.: +34-966-749-661
| |
Collapse
|
7
|
Recent updates in the polysaccharides-based Nano-biocarriers for drugs delivery and its application in diseases treatment: A review. Int J Biol Macromol 2021; 182:115-128. [PMID: 33836188 DOI: 10.1016/j.ijbiomac.2021.04.009] [Citation(s) in RCA: 32] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2021] [Revised: 04/02/2021] [Accepted: 04/02/2021] [Indexed: 01/02/2023]
Abstract
With people's increasing awareness of diseases treatment, the researchers began to focus on drug delivery to the exact site of action at the optimal rate. Some researchers have proved that many nanostructures loaded with drugs are significantly better than conventional nanostructures. However, the materials from which the nanostructure determines its performance. To use it as a pharmaceutical ingredient, it must meet strict safety regulatory standards worldwide. Therefore, people's attention has paid to easily available natural substances. As far as we know, bioactive polysaccharides are excellent candidates for realizing these purposes. To be precise, due to the natural availability of polysaccharides, it has been widely used in the research of Nano-biocarriers loaded with drugs. Based on the above analysis, the nanomaterials developed through the laboratory have great potential for upgrading to market products. Therefore, it is of great significance to review the latest progress of polysaccharide-based Nano-biocarriers in drug delivery and their application in diseases treatment. In this work, we focused on the preparation of polysaccharides-based Nano-biocarriers, commonly used polysaccharides for preparing Nano-biocarriers, and drugs loaded on polysaccharides-based Nano-biocarriers to treat diseases. Shortly, polysaccharide-based Nano-biocarriers will be increasingly used in drug delivery and treatment of diseases.
Collapse
|